Shopping Cart
Remove All
Your shopping cart is currently empty
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $147 | In Stock | In Stock | |
| 5 mg | $297 | In Stock | In Stock | |
| 10 mg | $478 | In Stock | In Stock | |
| 25 mg | $648 | In Stock | In Stock | |
| 50 mg | $817 | In Stock | In Stock | |
| 100 mg | $1,120 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $378 | In Stock | In Stock |
| Description | FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia. |
| Molecular Weight | 562.66 |
| Formula | C24H30N6O6S2 |
| Cas No. | 2671128-05-3 |
| Smiles | COC[C@H](NC(=O)c1ccn(c1)S(C)(=O)=O)C(=O)Nc1nc(cs1)-c1cccc(n1)N1C[C@H](C)O[C@H](C)C1 |
| Relative Density. | 1.46 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 245 mg/mL (435.43 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.